{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Fortress Biotech, Inc."},"Symbol":{"label":"Symbol","value":"FBIOP"},"Address":{"label":"Address","value":"1111 KANE CONCOURSE,SUITE 301, BAY HARBOR ISLAND, Florida, 33154, United States"},"Phone":{"label":"Phone","value":"+1 781 652-4500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors."},"CompanyUrl":{"label":"Company Url","value":"https://www.fortressbiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Lindsay Allan Rosenwald","title":"Executive Chairman, President & CEO"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}